{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:54:18Z","timestamp":1790862858099,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","award":["G-16-00013163"],"award-info":[{"award-number":["G-16-00013163"]}],"id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN-159928"],"award-info":[{"award-number":["FDN-159928"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN0159928"],"award-info":[{"award-number":["FDN0159928"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jtha.2025.06.028","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T19:24:46Z","timestamp":1752607486000},"page":"3198-3207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effects of milvexian alone or with heparin on catheter-induced clotting and thrombin generation"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6890-9964","authenticated-orcid":false,"given":"Ruiqi","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Fredenburgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey I.","family":"Weitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.06.028_bib1","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.jtha.2023.04.021","article-title":"News at XI: moving beyond factor Xa inhibitors","volume":"21","author":"Fredenburgh","year":"2023","journal-title":"J. Thromb. Haemost"},{"key":"10.1016\/j.jtha.2025.06.028_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1352734","article-title":"Anticoagulants for atrial fibrillation: from warfarin and DOACs to the promise of factor XI inhibitors","volume":"11","author":"Kumar","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jtha.2025.06.028_bib3","first-page":"e18","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"145","author":"JLawton","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2025.06.028_bib4","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1111\/jth.12961","article-title":"Medical device-induced thrombosis: what causes it and how can we prevent it?","volume":"13","author":"Jaffer","year":"2015","journal-title":"J. Thromb. Haemost"},{"key":"10.1016\/j.jtha.2025.06.028_bib5","doi-asserted-by":"crossref","first-page":"6667","DOI":"10.1182\/blood-2011-07-364141","article-title":"Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo","volume":"118","author":"Yau","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.06.028_bib6","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1016\/j.actbio.2012.07.019","article-title":"Corn trypsin inhibitor coating attenuates the prothrombotic properties of catheters in vitro and in vivo","volume":"8","author":"Yau","year":"2012","journal-title":"Acta Biomater"},{"key":"10.1016\/j.jtha.2025.06.028_bib7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1160\/TH12-10-0772","article-title":"General mechanisms of coagulation and targets of anticoagulants (Section I)","volume":"109","author":"De Caterina","year":"2013","journal-title":"Thromb. Haemost"},{"key":"10.1016\/j.jtha.2025.06.028_bib8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jtha.2022.10.020","article-title":"Rivaroxaban and apixaban are less effective than enoxaparin for the prevention of catheter-induced clotting in vitro","volume":"21","author":"Guan","year":"2023","journal-title":"J. Thromb. Haemost"},{"key":"10.1016\/j.jtha.2025.06.028_bib9","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1161\/ATVBAHA.123.319767","article-title":"PAR4 inhibition reduces coronary artery atherosclerosis and myocardial fibrosis in SR-B1\/LDLR double knockout mice","volume":"43","author":"Lee","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2025.06.028_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002322","article-title":"Dabigatran is less effective than warfarin at attenuating mechanical heart valve-induced thrombin generation","volume":"4","author":"Jaffer","year":"2015","journal-title":"J. Am. Heart Assoc"},{"key":"10.1016\/j.jtha.2025.06.028_bib11","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1182\/blood-2014-11-611319","article-title":"Arterial thrombosis is accelerated in mice deficient in histidine-rich glycoprotein","volume":"125","author":"Vu","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.06.028_bib12","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1126\/science.1652157","article-title":"Factor XI activation in a revised model of blood coagulation","volume":"253","author":"Gailani","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.jtha.2025.06.028_bib13","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/cts.13148","article-title":"First-in-human study of milvexian, an oral, direct, small molecule factor XIa inhibitor","volume":"15","author":"Perera","year":"2022","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jtha.2025.06.028_bib14","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1111\/bcp.15431","article-title":"A systematic review and meta-analysis of dabigatran peak and trough concentration in adults","volume":"88","author":"Ng","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jtha.2025.06.028_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2024.109194","article-title":"Development and validation of an in vitro model to study thrombin generation on the surface of catheters in platelet-poor and platelet-rich plasma","volume":"244","author":"Hardy","year":"2024","journal-title":"Thromb. Res"},{"key":"10.1016\/j.jtha.2025.06.028_bib16","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1182\/bloodadvances.2022009236","article-title":"Histidine-rich glycoprotein attenuates catheter thrombosis","volume":"7","author":"Malik","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.06.028_bib17","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1182\/blood-2013-12-540872","article-title":"Selective depletion of factor XI or factor XII with antisense oligonucleotides attenuates catheter thrombosis in rabbits","volume":"123","author":"Yau","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.06.028_bib18","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1182\/blood.V82.3.813.813","article-title":"Factor XII-independent activation of factor XI in plasma: effects of sulfatides on tissue factor-induced coagulation","volume":"82","author":"Gailani","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.06.028_bib19","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.108.789479","article-title":"Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non\u2013ST-segment elevation acute coronary syndromes","volume":"118","author":"Mehta","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2025.06.028_bib20","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.athoracsur.2019.10.091","article-title":"Rivaroxaban and dabigatran for suppression of mechanical heart valve-induced thrombin generation","volume":"110","author":"Jaffer","year":"2020","journal-title":"Ann. Thorac. Surg"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625004179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625004179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:23:27Z","timestamp":1790817807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625004179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1538783625004179"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.06.028","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of milvexian alone or with heparin on catheter-induced clotting and thrombin generation","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.06.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}